Feely J
Department of Pharmacology and Therapeutics and Pharmacoepidemiology and Medicines Evaluation Unit, Trinity College, Dublin 2, Ireland.
Br J Clin Pharmacol. 1993 Nov;36(5):483-6. doi: 10.1111/j.1365-2125.1993.tb00404.x.
The insatiable appetite for safer more effective, but increasingly more expensive, therapy in the face of increasing government reluctance to feed this demand has put the study of drug utilization and pharmacoeconomics centre stage. Clinical pharmacologists are uniquely positioned to determine the cost benefit and utility of modern therapy and give impartial advice on safe, effective and economic patient care. To mark the Quatercentenary Celebrations of Trinity College Dublin, eight speakers addressed this theme in a symposium held in conjunction with the British Pharmacological Society Meeting in July 1992.
面对政府越来越不愿意满足这种需求的情况，人们对更安全、更有效但越来越昂贵的治疗方法有着永不满足的需求，这使得药物利用和药物经济学的研究成为核心问题。临床药理学家处于独特的地位，能够确定现代治疗方法的成本效益和效用，并就安全、有效和经济的患者护理提供公正的建议。为纪念都柏林三一学院成立四百周年，八位演讲者在1992年7月与英国药理学会会议联合举办的一次研讨会上探讨了这一主题。
